Pharmaceutical companies launch new initiative to tackle NCDs

On Wednesday, a group of 22 pharmaceutical companies announced a new initiative aimed at tackling noncommunicable diseases and better assessing their individual, and collective, work to enable access to care in developing countries.

About the author

  • Adva Saldinger

    Adva Saldinger is an Associate Editor at Devex, where she covers the intersection of business and international development, as well as U.S. foreign aid policy. From partnerships to trade and social entrepreneurship to impact investing, Adva explores the role the private sector and private capital play in development. A journalist with more than 10 years of experience, she has worked at several newspapers in the U.S. and lived in both Ghana and South Africa.